Radiotherapy plus cetuximab vs cisplatin for locally advanced head and neck cancer

Cetuximab administered concomitantly with radiotherapy reduced adherence and increased acute toxicity rates compared with cisplatin plus radiotherapy in patients with locally advanced head and neck cancer, a new study published online ahead of print in the Journal of Clinical Oncology has shown.

Cancer Therapy Advisor